[1] |
Sung H,Ferlay J,Siegel RL,et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin,2021,71(3):209-249.
|
[2] |
韦静涛,季鑫,季加孚. 不断提高中国胃癌外科手术治疗规范化[J/CD]. 中华普外科手术学杂志(电子版),2022,16(03):237-241.
|
[3] |
陈凛,鲁意迅,张珂诚. 中国腹腔镜胃癌根治术术式选择与规范化[J/CD]. 中华普外科手术学杂志(电子版),2022,16(03):242-245.
|
[4] |
李乐平,杨建桥,商亮. 中国腹腔镜近远端胃癌切除精准淋巴结清扫与原则[J/CD]. 中华普外科手术学杂志(电子版),2022,16(03):246-250.
|
[5] |
Kitano S,Iso Y,Moriyama M,et al. Laparoscopy-assisted Billroth I gastrectomy[published correction appears in Surg Laparosc Endosc[J]. Surg Laparosc Endosc,1994,4(2):146-148.
|
[6] |
Hiki N,Katai H,Mizusawa J,et al. Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer:a multicenter phase II trial(JCOG0703)[J]. Gastric Cancer,2018,21(1):155-161.
|
[7] |
Katai H,Mizusawa J,Katayama H,et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer:Japan Clinical Oncology Group Study JCOG0912[J]. Gastric Cancer,2017,20(4):699-708.
|
[8] |
Kim HH,Han SU,Kim MC,et al. Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer:The KLASS-01 Randomized Clinical Trial[J]. JAMA Oncol,2019,5(4):506-513.
|
[9] |
Hyung WJ,Yang HK,Han SU,et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer:a prospective multi-center phase II clinical trial,KLASS 03[J]. Gastric Cancer,2019,22(1):214-222.
|
[10] |
Liu F,Huang C,Xu Z,et al. Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer:The CLASS02 Multicenter Randomized Clinical Trial[J]. JAMA Oncol,2020,6(10):1590-1597.
|
[11] |
Yu J,Huang C,Sun Y,et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer:The CLASS-01 Randomized Clinical Trial[J]. JAMA,2019,321(20):1983-1992.
|
[12] |
中国抗癌协会胃癌专业委员会. 局部进展期胃癌规范化淋巴结清扫范围中国专家共识(2022版)[J]. 中华胃肠外科杂志,2022,25(04):277-283.
|
[13] |
Songun I,Putter H,Kranenbarg EM,et al. Surgical treatment of gastric cancer:15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncol,2010,11(5):439-449.
|
[14] |
苗儒林,李子禹,武爱文. 中国胃肠肿瘤外科联盟数据报告(2014-2016)[J]. 中国实用外科杂志,2018,38(01):90-93.
|
[15] |
Wu L,Zhang C,Liang Y,et al. Risk factors for metastasis to No.14v lymph node and prognostic value of 14v status for gastric cancer patients after surgery[J]. Jpn J Clin Oncol,2018,48(4):335-342.
|
[16] |
Japanese Gasstric Cancer Association. Japanese gastric cancer treatment guidelines 2018(5th edition)[J]. Gastric Cancer,2021,24(1):1-21.
|
[17] |
Zheng C,Xu Y,Zhao G,et al. Outcomes of laparoscopic total gastrectomy combined with spleen-preserving hilar lymphadenectomy for locally advanced proximal gastric cancer:a nonrandomized clinical trial[J]. JAMA Netw Open,2021,4(12):e2139992.
|
[18] |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)胃癌诊疗指南2021[M]. 北京:人民卫生出版社,2021:1-169.
|
[19] |
黄昌明,郑朝辉,陆俊. 完全腹腔镜胃癌手术消化道重建专家共识及手术操作指南(2018版)[J]. 中国实用外科杂志,2018,38(08):833-839.
|
[20] |
季加孚,胡祥,陈凛,等. 胃切除术后消化道重建技术专家共识[J]. 中国实用外科杂志,2014,34(03):205-212.
|
[21] |
Nakamura T,Hojo Y,Kumamoto T,et al. History of the lymph node numbering system in the Japanese Classification of Gastric Carcinoma since 1962[J]. Surg Today,2022,52(11):1515-1523.
|
[22] |
中国抗癌协会胃癌专业委员会,中国抗癌协会肿瘤胃肠病学专业委员会. 胃癌根治术标本的规范化外科处理中国专家共识(2022版)[J]. 中华胃肠外科杂志,2022,25(02):93-103.
|
[23] |
Zheng CH,Lu J,Zheng HL,et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer:A phase 3 randomized controlled trial[J]. Surgery,2018,163(2):300-304.
|
[24] |
黄昌明,郑朝辉,陈起跃. 吲哚菁绿近红外光成像在腹腔镜胃癌根治术中应用中国专家共识(2019版)[J]. 中国实用外科杂志,2020,40(02):139-144.
|